1,099
Views
8
CrossRef citations to date
0
Altmetric
Research Papers

The cost effectiveness of rotavirus vaccination in Iran

, , , , , , , & show all
Pages 794-800 | Received 01 Apr 2015, Accepted 23 Aug 2015, Published online: 05 May 2016

References

  • Rheingans RD, Antil L, Dreibelbis R, Podewils LJ, Bresee JS, Parashar UD. Economic costs of rotavirus gastroenteritis and cost-effectiveness of vaccination in developing countries. J Infect Dis 2009/11/1; 200 Suppl 1:S16-S27; PMID:19817595; http://dx.doi.org/10.1086/605026
  • WHO. Rotavirus vaccines WHO position paper- January 2013. Weekly Epidemiological Record 13 AD/1/2; 88:49-64
  • Ogilvie I, Khoury H, El Khoury AC, Goetghebeur MM. Burden of rotavirus gastroenteritis in the pediatric population in Central and Eastern Europe: serotype distribution and burden of illness. Hum Vaccin 2011/5; 7:523-33
  • Khoury H, Ogilvie I, El Khoury AC, Duan Y, Goetghebeur MM. Burden of rotavirus gastroenteritis in the Middle Eastern and North African pediatric population. BMC Infect Dis 2011; 11:9; PMID:21214934; http://dx.doi.org/10.1186/1471-2334-11-9
  • Velazquez FR, Matson DO, Calva JJ, Guerrero L, Morrow AL, Carter-Campbell S, Glass RI, Estes MK, Pickering LK, Ruiz-Palacios GM. Rotavirus infections in infants as protection against subsequent infections. N Engl J Med 1996/10/3; 335:1022-8; PMID:8793926; http://dx.doi.org/10.1056/NEJM199610033351404
  • Kuehn BM. High rotavirus vaccination rates continue to pay off. JAMA 2014/7/2; 312:18; PMID:25058201; http://dx.doi.org/10.1001/jama.2014.7939
  • Vesikari T. Rotavirus vaccination: a concise review. Clin Microbiol Infect 2012/10; 18 Suppl 5:57-63; PMID:22882248; http://dx.doi.org/10.1111/j.1469-0691.2012.03981.x
  • Gagneur A, Nowak E, Lemaitre T, Segura JF, Delaperriere N, Abalea L, Poulhazan E, Jossens A, Auzanneau L, Tran A, et al. Impact of rotavirus vaccination on hospitalizations for rotavirus diarrhea: the IVANHOE study. Vaccine 2011/5/12; 29:3753-9; PMID:21443962; http://dx.doi.org/10.1016/j.vaccine.2011.03.035
  • Braeckman T, Van Herck K, Raes M, Vergison A, Sabbe M, Van Damme P. Rotavirus vaccines in Belgium: policy and impact. Pediat Infect Dis J 2011; 30:S21-4; PMID:21183836; http://dx.doi.org/10.1097/INF.0b013e3181fefc51
  • Giaquinto C, Dominiak-Felden G, Van DP, Myint TT, Maldonado YA, Spoulou V, Mast TC, Staat MA. Summary of effectiveness and impact of rotavirus vaccination with the oral pentavalent rotavirus vaccine: a systematic review of the experience in industrialized countries. Hum Vaccin 2011/7; 7:734-48
  • Fernandes EG, Sato HK, Leshem E, Flannery B, Konstantyner TC, Veras MA, Patel MM. Impact of rotavirus vaccination on diarrhea-related hospitalizations in Sao Paulo State, Brazil. Vaccine 2014/6/5; 32:3402-8; PMID:24736002; http://dx.doi.org/10.1016/j.vaccine.2014.04.015
  • Atherly D, Dreibelbis R, Parashar UD, Levin C, Wecker J, Rheingans RD. Rotavirus vaccination: cost-effectiveness and impact on child mortality in developing countries. J Infect Dis 2009; 200 Suppl 1:S28-38; PMID:19817610; http://dx.doi.org/10.1086/605033
  • Podewils LJ, Antil L, Hummelman E, Bresee J, Parashar UD, Rheingans R. Projected cost-effectiveness of rotavirus vaccination for children in Asia. J Infect Dis 2005/9/1; 192 Suppl 1:S133-S45; PMID:16088797; http://dx.doi.org/10.1086/431513
  • Sigei C, Odaga J, Mvundura M, Madrid Y, Clark AD. Cost-effectiveness of rotavirus vaccination in Kenya and Uganda. Vaccine 2015/5/7; 33 Suppl 1:A109-A18; PMID:25919149; http://dx.doi.org/10.1016/j.vaccine.2014.12.079
  • Diop A, Atherly D, Faye A, Lamine SF, Clark AD, Nadiel L, Yade B, Ndiaye M, Fafa CM, Ba M. Estimated impact and cost-effectiveness of rotavirus vaccination in Senegal: a country-led analysis. Vaccine 2015/5/7; 33 Suppl 1:A119-A25; PMID:25919151; http://dx.doi.org/10.1016/j.vaccine.2014.12.065
  • Ahmeti A, Preza I, Simaku A, Nelaj E, Clark AD, Felix Garcia AG, Lara C, Hoestlandt C, Blau J, Bino S. Cost-effectiveness of rotavirus vaccination in Albania. Vaccine 2015; 33 Suppl 1:A201-8; PMID:25919162; http://dx.doi.org/10.1016/j.vaccine.2014.12.075
  • Javanbakht M, Moradi-Lakeh M, Yaghoubi M, Esteghamati A, Mansour GR, Mahmoudi S, Shamshiri AR, Zahraei SM, Baxter L, Shakerian S, et al. Cost-effectiveness analysis of the introduction of rotavirus vaccine in Iran. Vaccine 2015/5/7; 33 Suppl 1:A192-A200; PMID:25919160; http://dx.doi.org/10.1016/j.vaccine.2014.12.035
  • Madsen LB, Ustrup M, Fischer TK, Bygbjerg IC, Konradsen F. Reduced price on rotavirus vaccines: enough to facilitate access where most needed? Bull World Health Organ 2012/7/1; 90:554-6
  • Jain S, Vashistt J, Changotra H. Rotaviruses: is their surveillance needed? Vaccine 2014/6/5; 32:3367-78; PMID:24793942; http://dx.doi.org/10.1016/j.vaccine.2014.04.037
  • Kim SY, Goldie SJ, Salomon JA. Cost-effectiveness of Rotavirus vaccination in Vietnam. BMCPublic Health 2009; 9:29; PMID:19159483; http://dx.doi.org/10.1186/1471-2458-9-29
  • Ortega O, El-Sayed N, Sanders JW, bd-Rabou Z, Antil L, Bresee J, Mansour A, Adib I, Nahkla I, Riddle MS. Cost-benefit analysis of a rotavirus immunization program in the Arab Republic of Egypt. JInfectDis 2009/11/1; 200 Suppl 1:S92-S8; PMID:19817621; http://dx.doi.org/10.1086/605057
  • Malek MA, Teleb N, bu-Elyazeed R, Riddle MS, Sherif ME, Steele AD, Glass RI, Bresee JS. The epidemiology of rotavirus diarrhea in countries in the Eastern Mediterranean Region. JInfectDis 2010/9/1; 202 Suppl:S12-S22; PMID:20684691; http://dx.doi.org/10.1086/653579
  • World Health Organization. Cost effectiveness and strategic planning (WHO-CHOICE). Available at http://www.who.int/choice/en/
  • Glass RI, Parashar UD, Bresee JS, Turcios R, Fischer TK, Widdowson MA, Jiang B, Gentsch JR. Rotavirus vaccines: current prospects and future challenges. Lancet 2006/7/22; 368:323-32; PMID:16860702; http://dx.doi.org/10.1016/S0140-6736(06)68815-6
  • Eesteghamati A, Gouya M, Keshtkar A, Najafi L, Zali MR, Sanaei M, Yaghini F, El MH, Patel M, Klena JD, et al. Sentinel hospital-based surveillance of rotavirus diarrhea in iran. JInfectDis 2009/11/1; 200 Suppl 1:S244-S7; PMID:19821714; http://dx.doi.org/10.1086/605050
  • Hamkar R, Yahyapour Y, Noroozi M, Nourijelyani K, Jalilvand S, Adibi L, Vaziri S, Poor-Babaei A, Pakfetrat A, Savad-Koohi R. Prevalence of rotavirus, adenovirus, and astrovirus infections among patients with acute gastroenteritis in, Northern Iran. Iran JPublic Health 2010; 39:45-51; PMID:23113006
  • Khalili B, Cuevas LE, Reisi N, Dove W, Cunliffe NA, Hart CA. Epidemiology of rotavirus diarrhoea in Iranian children. JMedVirol 2004/6; 73:309-12; PMID:15122809
  • Modaress S, Rahbarimanesh AA, Edalat R, Sohrabi A, Modarres S, Gomari H, Motamedirad M, Sayari AA. Human rotavirus genotypes detection among hospitalized children, a study in Tehran, Iran. ArchIran Med 2011/1; 14:39-45
  • Modarres S, Rahbarimanesh AA, Karimi M, Modarres S, Motamedi-Rad M, Sohrabi A, Nasiri-Oskoii N. Electrophoretic RNA genomic profiles of rotavirus strains prevailing among hospitalized children with acute gastroenteritis in tehran, iran. ArchIran Med 2008/9; 11:526-31; PMID:18759520
  • Modarres S MS, Nassiri Oskoii N. Rotavirus Infection in Infants and young children with acute gastroenteraritis in the Islamic Republic of Iran. Eastern Mediterranean Health Journal 1995; 7:210-4
  • Emamghorashi F, Rajabi SH, Shadman A. Frequency of Rotavirus Infection in Children with Acute Gastroenteritis in Jahrom, South of Iran. Iran J Med Sci 2008; 33:84-7.
  • Sadeghian A, Hamedi A, Sadeghian M, Sadeghian H. Incidence of rotavirus diarrhea in children under 6 years referred to the Pediatric Emergency and Clinic of Ghaem Hospital, Mashhad, Iran. Acta MedIran 2010/7; 48:263-5
  • Kargar M, Akbarizadeh AR. Prevalence and molecular genotyping of group a rotaviruses in Iranian children. Indian JVirol 2012/6; 23:24-8; PMID:23729998; http://dx.doi.org/10.1007/s13337-012-0070-7
  • Kargar M, Khodadadi P, Najafi A, Ansari H. Predominance of rotavirus G8 genotype in hospitalized children with acute gastroenteritis in Yasuj, Iran. EurRevMedPharmacolSci 2014; 18:699-702
  • Kolahi AA, Rastegarpour A, Abadi A, Gachkar L. An unexpectedly high incidence of acute childhood diarrhea in Koot-Abdollah, Ahwaz, Iran. Int J InfectDis 2010/7; 14:e618-e21; PMID:20116314; http://dx.doi.org/10.1016/j.ijid.2009.10.001
  • Rashidian A, Khosravi A, Khabiri R, Khodayari-Moez E, Elahi E, Arab M, Radaie Z. Islamic Republic of Iran's Multiple-Indicator Demographic and Health Survey (IrMIDHS) 2010. Tehran, Iran: Ministry of Health and Medical Education; 2012
  • World Health Organization. Estimated rotavirus deaths for children under 5 years of age: 2008. Available at http://www.who.int/immunization/monitoring_surveillance/burden/estimates/rotavirus/en/
  • World Health Organization. Guidelines for estimating the economic burden of diarrhoeal disease with focus on assessing the cost of rotavirus diarrhoeal. Geneva, Switzerland: World Health Organization, Department of Immunization, Vaccines and Biologicals; 2005
  • Motlagh ME, Heidarzadeh A, Hashemian H, Dosstdar M. Patterns of care seeking during episodes of childhood diarrhea and its relation to preventive care patterns: national integrated monitoring and evaluation survey (IMES) of Family Health. Islamic Republic of Iran. Int JPrevMed 2012/1; 3:60-7
  • Cheraghali AM, Nikfar S, Behmanesh Y, Rahimi V, Habibipour F, Tirdad R, Asadi A, Bahrami A. Evaluation of availability, accessibility and prescribing pattern of medicines in the Islamic Republic of Iran. Eastern Mediterranean Health J = La Revue de Sante de la Mediterranee Orientale = al-Majallah al-sihhiyah li-sharq al-Mutawassit 2004; 10:406-15
  • Iranian Medical Council, Prescribing tariff, Medical Council of I.R.Iran. Available at http://irimc.org/DynamicContentaspx?ci=6c4f49db-aaaa-4e0c-8692-d3fea9e9fdf5 (site in Farsi Language).
  • Statistical Center of Iran. Average annual income of an Urban/Rural household. Available at http://www.amar.orgir/Defaultaspx?tabidD496
  • Wolfson LJ, Gasse F, Lee-Martin SP, Lydon P, Magan A, Tibouti A, Johns B, Hutubessy R, Salama P, Okwo-Bele JM. Estimating the costs of achieving the WHO-UNICEF global immunization vision and strategy, 2006-2015. Bull World Health Organ 2008/1; 86:27-39; PMID:18235887; http://dx.doi.org/10.2471/BLT.07.045096
  • Jit M, Yuzbashyan R, Sahakyan G, Avagyan T, Mosina L. The cost-effectiveness of rotavirus vaccination in Armenia. Vaccine 2011/11/8; 29:9104-11; PMID:21945959; http://dx.doi.org/10.1016/j.vaccine.2011.08.127
  • Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006/1/5; 354:11-22; PMID:16394298; http://dx.doi.org/10.1056/NEJMoa052434
  • Fox-Rushby JA, Hanson K. Calculating and presenting disability adjusted life years (DALYs) in cost-effectiveness analysis. Health Policy Plan 2001/9; 16:326-31; PMID:11527874; http://dx.doi.org/10.1093/heapol/16.3.326
  • Murray CJL, Lopez AD. Global Burden of Disease: A comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. World Health Organization, 1996.
  • World Health Organization. Global estimates of burden of disease caused by the environment and occupational risks, 2009. Available at http://appswho.int/gho/data/?themeDmain&vidD60760/

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.